After suffering from treatment-resistant laryngitis for five years, a second opinion consult leads to the discovery of a rare bacterial infection.
New study finds 68 percent of patients with unexplained chronic cough get relief from neuromodulators, but more than half are affected by tachypylaxis or dependence. Otolaryngologist Paul Bryson, MD and pulmonologist Rachel Taliercio, DO, explain their findings.
Staff members of Cleveland Clinic’s Head & Neck Institute studied technologies available for distance health and how they can be used to enhance care for laryngology patients. They recently published their results.
A retrospective study looking at how dysphonia affects the U.S. population was led by Michael S. Benninger, MD, Chairman of Cleveland Clinic’s Head & Neck Institute.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
For nearly 20 years Dr. Benninger has led the Head & Neck team and he is as enthusiastic today about medicine as he was when he started. Learn why he became a physician and how he finds the balance between work and life.
Cleveland Clinic investigates expanded use of a sleep positioning device to alleviate the symptoms of nocturnal reflux – even for hard-to-treat patients.
Earlier intervention in chronic rhinosinusitis may become an effective strategy to improve patient outcomes and quality of life and reduce healthcare resource utilization.